CX 2013 Presentations 2017-08-01T13:02:23+00:00

CX 2013 Presentations

CX37
CX35 Vascular & Endovascular Challenges Update Saturday 06 April

Training Challenges Chairman Julian Scott, Leeds, United Kingdom 08:29 to 09:15
Training in advanced imaging Giovanni Torsello, Muenster, Germany 08:30 to 08:35
A new training programme for vascular and endovascular surgeons of the future Cliff Shearman, Southampton, United Kingdom 08:35 to 08:40
Vascular surgery as an independent speciality Florian Dick, Bern, Switzerland 08:45 to 08:50
How can vascular trainees and young vascular surgeons best be trained in endovascular techniques? Frank Vermassen, Ghent, Belgium 08:50 to 08:55
Open and endovascular training methods today Hans-Henning Eckstein, Munich, Germany 08:55 to 09:00
Implementation of simulation training for rEVAR programmes Mario Lachat, Zurich, Switzerland 09:00 to 09:05
Panel discussion 09:05 to 09:14
Peripheral Arterial Challenges Chairman Malcolm Simms, Birmingham, United Kingdom 09:14 to 10:00
3D image overlay to assist peripheral endovascular procedure Jos van den Berg, Lugano, Switzerland 09:15 to 09:20
Intermittent claudication and chronic limb (critical) ischaemia are approached differently Roberto Ferraresi, Milan, Italy 09:20 to 09:25
Panel discussion 09:25 to 09:35
Clinical evidence and gap analysis in intermittent claudication Erich Minar, Vienna, Austria 09:35 to 09:40
Rotarex and drug eluting balloons Sven Braeunlich, Leipzig, Germany 09:45 to 09:50
Panel discussion and presentation to the Circulation Foundation 09:50 to 10:00
Peripheral Arterial Challenges: Intermittent claudication challenges: Trial data Chairman Frans Moll, Utrecht, Netherlands 10:29 to 12:30
PERFECTION trial - the FUSION graft for supragenuale femoropopliteal bypass Afshin Assadian, Vienna, Austria 10:30 to 10:35
Panel discussion 10:45 to 10:50
Nordic walking - more effective than standard exercise programme for claudicants? Jonathan Beard, Sheffield, United Kingdom 10:50 to 10:55
Panel discussion 10:55 to 11:00
The RELINE trial: VIABAHN vs balloon angioplasty (PoBA) at 6 months Marc Bosiers, Dendermonde, Belgium 11:00 to 11:05
Panel discussion 11:05 to 11:10
Improved 3-year patency rates of Heparin-bonded ePTFE vs standard ePTFE Russell H Samson, Sarasota, United States 11:15 to 11:20
Panel discussion 11:20 to 11:30
6-month single centre patency data for dual component bare metal stent in the superficial femoral artery Michael Piorkowski, Leipzig, Germany 11:30 to 11:35
A sutureless anastomosis Jeffrey Wang, Rockville, United States 11:35 to 11:40
Panel discussion 11:40 to 11:50
Long-term outcomes of envascular popliteal aneurysm treatment are similar to open repair Michel Makaroun, Pittsburgh, United States 11:50 to 11:55
Panel discussion Jacques Busquet, Paris, France 11:55 to 12:00
Plain old balloons and stents reign supreme in the superficial femoral artery Frank Criado, Baltimore, United States 12:00 to 12:05
Drug eluting stent vs open bypass Marc Bosiers, Dendermonde, Belgium 12:05 to 12:10
Zilver PTX 3-year results Michael Dake, Stanford, United States 12:10 to 12:15
Panel discussion 12:15 to 12:30
Peripheral Arterial Challenges: Intermittent claudication challenges: Stenting data (cont'd) Chairman Iris Baumgartner, Bern, Switzerland 13:29 to 15:30
Durability and trials: 12 months results of primary stenting with the Protege Everflex and stent system for superficial femoral artery lesions Patrick Peeters, Bonheiden, Belgium 13:30 to 13:35
The role of drug eluting therapies for claudication - drug eluting stents Michael Dake, Stanford, United States 13:35 to 13:40
Drug eluting balloons vs drug eluting stents in the superficial femoral artery for intermittent claudication Thomas Zeller, Bad Krozingen, Germany 13:40 to 13:45
Panel discussion 13:45 to 13:55
Initial evidence for drug eluting balloons for in stent stenosis in the superficial femoral artery Eugenio Stabile, Salerno, Italy 13:55 to 14:00
Panel discussion 14:05 to 14:15
Meta-analysis of drug eluting balloons for superficial femoral artery revascularisation Massimiliano Fusaro, Munich, Germany 14:15 to 14:20
Clinical and cost aspects of drug elution Michael Jaff, Boston, United States 14:20 to 14:25
Panel discussion 14:25 to 14:35
The role of bioresorbable stents in the superficial femoral artery Frank Vermassen, Ghent, Belgium 14:35 to 14:40
Body of evidence for drug eluting stents below the knee: DESTINY, YUKON and ACHILLES trials Koen Deloose, Dendermonde, Belgium 14:40 to 14:45
Panel discussion 14:45 to 14:55
The importance of foot wound debridement with reconstruction Keith Jones, London, United Kingdom 14:55 to 15:00
Diagnosis of acute limb ischaemia - why is it missed so often? Cliff Shearman, Southampton, United Kingdom 15:00 to 15:05
Evolution of peripheral blood flow by perfusion imaging Peter Ashley Robless, Singapore, Singapore 15:05 to 15:10
Critical limb ischaemia epidemic and therapy mandates (or objectives) in the modern era Carlo Caravaggi, Milan, Italy 15:10 to 15:15
Panel discussion 15:15 to 15:30
Peripheral Arterial Challenges: Critical limb ischaemia challenges (cont'd) Chairman Roger Greenhalgh, London, United Kingdom 15:59 to 17:45
Clinical evidence and current practice in critical limb ischaemia revascularisation: Critical review and gap analysis Krishna Rocha Singh, Springfield, United States 16:00 to 16:05
Drug coated balloon vs Zilver PTX in long femoro-popliteal lesions Thomas Zeller, Bad Krozingen, Germany 16:05 to 16:10
Panel discussion 16:10 to 16:25
Proximal reconstruction with stem cell usage Vaclav Prochazka, Ostrava, Czech Republic 16:25 to 16:30
Stem mobilisation shows trend in improving amputation rate in critical limb ischaemia Eric Choi, Philadelphia, United States 16:30 to 16:35
Panel discussion 16:35 to 16:45
Vessel patency and tissue care - the critical synergy Frank Vermassen, Ghent, Belgium 16:45 to 16:50
Bollinger risk score - prediction of success for crural angioplasty David Russell, Leeds, United Kingdom 16:50 to 16:55
PoBA angioplasty reigns supreme for below the knee revascularisation Iris Baumgartner, Bern, Switzerland 16:55 to 17:00
Panel discussion 17:00 to 17:15
The importance of early referral and interdisciplinary management Michael Edmonds, London, United Kingdom 17:15 to 17:20
The body of evidence for drug eluting balloons below the knee Dierk Scheinert, Leipzig, Germany 17:20 to 17:25
Lack of evidence and future expectations in critical limb ischaemia Iris Baumgartner, Bern, Switzerland 17:25 to 17:30
Panel discussion 17:30 to 17:45
Sunday 07 April

Abdominal Aortic Challenges Chairman Janet Powell, London, United Kingdom 08:00 to 10:00
Advanced hybrid suite imaging is the key to surgical advance Nung Rudarakanchana, London, United Kingdom 08:00 to 08:05
The optimal imaging and planning for abdominal aortic aneurysm Lieven Maene, Aalst, Belgium 08:05 to 08:10
Benefits of Innova Vision Technology with first GE Discovery experience Stephan Haulon, Lille, France 08:10 to 08:15
Panel discussion 08:15 to 08:30
Aortic bifurcation reconstruction Michel Reijnen, Arnhem, Netherlands 08:30 to 08:35
Endovascular aortic aneurysm repair in patients with narrow aortas using bifurcated devices Gustavo Oderich, Rochester, United States 08:35 to 08:40
Panel discussion 08:40 to 08:50
Optimising an abdominal aortic aneurysms screening programme Jonothan Earnshaw, Gloucester, United Kingdom 08:50 to 08:55
Smoking habits among patients with screening programme Anders Wanhainen, Uppsala, Sweden 08:55 to 09:00
Panel discussion 09:05 to 09:20
Tortuous iliac arteries: What does the data tell us about limb patency? Hence Verhagen, Rotterdam, Netherlands 09:20 to 09:25
Effect of internal iliac artery interruption: Is preservation a must? Piergiorgio Cao, Rome, Italy 09:25 to 09:30
Panel discussion 09:30 to 09:40
General anaesthesia is associated with adverse cardiac outcome after endovascular aneurysm repair Hence Verhagen, Rotterdam, Netherlands 09:40 to 09:45
Panel discussion 09:50 to 10:00
Abdominal Aortic Challenge: Abdominal aortic aneurysm update (cont'd) Chairman Roger Greenhalgh, London, United Kingdom 10:29 to 12:30
12-month results of the TREOVANCE abdominal stent graft: A metanalysis from ADVANCE and BENEFITclinical studies Matthew J Eagleton, Cleveland, United States 10:30 to 10:35
Panel discussion 10:35 to 10:40
Durability paired with innovation: Going low profile should not compromise device performance Scott Stevens, Knoxville, United States 10:40 to 10:45
Zenith TX2-LP 6-month clinical trial results Giovanni Torsello, Muenster, Germany 10:45 to 10:50
Larger aortic diameters: Do we need to rewrite the evidence based challenges in EVAR? Robert Fisher, Liverpool, United Kingdom 10:50 to 10:55
Panel discussion 10:55 to 11:05
Expanding EVAR safely - on-label treatment of patients with abdominal aortic aneurysm Manish Mehta, Albany, United States 11:05 to 11:10
The PYTHAGORAS trial for 60' - 90' angle aortic neck Mark Fillinger, Lebanon, United States 11:10 to 11:15
Panel discussion 11:15 to 11:25
Detecting Type 2 endoleak at operation Alan B Lumsden, Houston, United States 11:25 to 11:30
Type 2 endoleak is detected best by MR angiography Frans Moll, Utrecht, Netherlands 11:30 to 11:35
Direct sac puncture embolisation is the method of choice for Type 2 endoleaks Robert Morgan, London, United Kingdom 11:35 to 11:40
Panel discussion 11:40 to 11:50
Type 2 endoleak is not benign and can be treated by injected liquid embolic embolic agent Jean-Pierre Becquemin, Creteil, France 11:50 to 11:55
Randomised routine deployment with coils and glues to reduce EVAR Type 2 endoleaks Paolo Frigatti, Udine, Italy 11:55 to 12:00
Type 2 endoleaks should be embolised after EVAR and TEVAR Robert Morgan, London, United Kingdom 12:00 to 12:05
Type 2 endoleak is not worth treating at all Hence Verhagen, Rotterdam, Netherlands 12:10 to 12:15
Panel discussion 12:15 to 12:30
Abdominal Aortic Challenge: Abdominal aortic aneurysm update (cont'd) Chairman Eric Verhoeven, Nuremberg, Germany 13:29 to 15:30
Debate - For the motion: Preoperative factors determine long-term EVAR outcomes Frans Moll, Utrecht, Netherlands 13:30 to 13:35
Debate - Against the motion: Preoperative factors determine long-term EVAR outcomes Thomas Wyss, Haegendorf, Switzerland 13:35 to 13:40
Panel discussion 13:40 to 13:50
Routine use of ultrasound guidance and micropuncture has made endovascular access safer Peter Schneider, Honolulu, United States 13:50 to 13:55
Discussion on bell bottom grafts for off-label use (e.g. iliacs >21mm, with thrombus and no good neck) Gustavo Oderich, Rochester, United States 13:55 to 14:00
Panel discussion 14:00 to 14:10
The influence of neck thrombus on clinical outcome and aneurysm morphology after EVAR Hence Verhagen, Rotterdam, Netherlands 14:10 to 14:15
There are no accepted guidelines on how to assess neck thrombus and calcification Florian Dick, Bern, Switzerland 14:15 to 14:20
Panel discussion 14:20 to 14:30
The treatment of short angulated necks by EVAR Tulio Navarro, Belo Horizonte, Brazil 14:30 to 14:35
Gender and initial aortic aneurysm diameter influence on EVAR outcome Mark Fillinger, Lebanon, United States 14:35 to 14:40
Panel discussion 14:40 to 14:50
OVER trial: Eight-year results Frank Lederle, Minneapolis, United States 14:50 to 14:55
Panel discussion 15:00 to 15:10
Cost effectiveness comparison in EVAR, DREAM, ACE and OVER trials David Epstein, York, United Kingdom 15:10 to 15:15
Cost effectiveness of endovascular repair on OVER data Frank Lederle, Minneapolis, United States 15:15 to 15:20
Panel discussion 15:20 to 15:30
Abdominal Aortic Challenge: Abdominal aortic aneurysm update (cont'd) Chairman Hence Verhagen, Rotterdam, Netherlands 16:29 to 18:00
Importance of family history on the morphology and aggressiveness of aortic disease Tara Mastracci, Cleveland, United States 16:30 to 16:35
The place of intravascular ultrasound with EVAR and TEVAR Rodney White, Torrance, United States 16:35 to 16:40
Complications of closure devices Raman Uberoi, Oxford, United Kingdom 16:40 to 16:45
Early experiences with intravascular robotics for EVAR Jean-Pierre Becquemin, Creteil, France 16:45 to 16:50
Panel discussion 16:50 to 17:05
Optimising the work flow of diagnosis and therapy Markus Steinbauer, Regensburg, Germany 17:05 to 17:10
The uncertainty is over: Do it by EVAR Frank Veith, New York, United States 17:10 to 17:15
Panel discussion 17:15 to 17:20
Great debate - For the motion: Ruptured abdominal aortic aneurysm mandate management by EVAR almost always Dieter Mayer, Zurich, Switzerland 17:20 to 17:25
Great debate - For the motion: Ruptured abdominal aortic aneurysm mandate management by EVAR almost always Thomas Larzon, Orebro, Sweden 17:25 to 17:30
Great debate - Against the motion: Ruptured abdominal aortic aneurysm mandate management by EVAR almost always Ron Balm, Amsterdam, Netherlands 17:30 to 17:35
Great debate - Against the motion: Ruptured abdominal aortic aneurysm mandate management by EVAR almost always Janet Powell, London, United Kingdom 17:35 to 17:40
Discussion and Vote 17:40 to 17:55
Monday 08 April

Thoracic Challenges Chairman Peter Taylor, London, United Kingdom 07:59 to 10:00
For which type of procedure is a hybrid room mandatory? Eric Verhoeven, Nuremberg, Germany 08:00 to 08:05
Computed tomography overlay for guidance of fenestrated EVAR is a clinical nicety or necessity Hicham Kobeiter, Creteil Cedex, France 08:05 to 08:10
Panel discussion 08:10 to 08:20
Panel discussion 08:30 to 08:40
Great debate - For the motion: Fusion of preoperative datasets is ideal Tara Mastracci, Cleveland, United States 08:40 to 08:45
Great debate - For the motion: Fusion of preoperative datasets is ideal Jos van den Berg, Lugano, Switzerland 08:45 to 08:50
Great debate - Against the motion: Fusion of preoperative datasets is ideal Krassi Ivancev, London, United Kingdom 08:50 to 08:55
Discussion and Vote 09:00 to 09:15
Relevance of radial fit in effective aortic treatment: Analysis of multiple studies and thoracic Registry oversizing outcomes Mark Fillinger, Lebanon, United States 09:15 to 09:20
Saccular thoracic aneurysms may justify different instructions for use than fusiform ones Frank Criado, Baltimore, United States 09:20 to 09:25
Panel discussion 09:25 to 09:35
Centralisation of complex aortic repair may help to improve patient outcomes and to contain the cost Piergiorgio Cao, Rome, Italy 09:35 to 09:40
Are more thoracic endovascular procedures being done - and why is this? Martin Czerny, Bern, Switzerland 09:40 to 09:45
Panel discussion 09:45 to 10:00
Thoracic Challenges: Ascending aorta and arch challenges Chairman Andrew Holden, Auckland, New Zealand 10:29 to 12:30
Acute aortic syndrome Peter Taylor, London, United Kingdom 10:30 to 10:35
Total endovascular arch reconstruction Krassi Ivancev, London, United Kingdom 10:35 to 10:40
Panel discussion 10:40 to 10:50
TEVAR for ascending aortic disease Rodney White, Torrance, United States 10:50 to 10:55
The durability of branched grafts Tara Mastracci, Cleveland, United States 10:55 to 11:00
Panel discussion 11:00 to 11:10
Hybrid repair of aortic arch aneurysms and dissections - lessons learned after 160 cases Roberto Chiesa, Milan, Italy 11:10 to 11:15
How to improve the endograft conformability in the arch Vincent Riambau, Barcelona, Spain 11:15 to 11:20
Panel discussion 11:20 to 11:30
Clinical results for RELAY in the TEVAR worldwide RESTORE 2 Registry Martin Funovics, Vienna, Austria 11:30 to 11:35
A new hybrid graft for fast ascending / arch and descending aortic replacement Heinz Gunther Jakob, Essen, Germany 11:35 to 11:40
Arch and visceral hybrid reconstruction John Wolfe, London, United Kingdom 11:50 to 11:55
Ascending aortic stent grafts - indications and limitations Ralf Kolvenbach, Duesseldorf, Germany 11:55 to 12:00
Panel discussion 12:00 to 12:10
Intra-operative imaging for antegrade repair of thoracic dissections Heinz Gunther Jakob, Essen, Germany 12:10 to 12:15
Medical management is still the treatment of choice for uncomplicated Type B aortic dissection Ali Azizzadeh, Houston, United States 12:15 to 12:20
Panel discussion 12:20 to 12:30
Thoracic Challenges: Uncomplicated Type B dissecting aneurysm challenges Chairman Frans Moll, Utrecht, Netherlands 13:29 to 15:30
Uncomplicated Type B dissection - how to predict who to intervene on Michael Jenkins, London, United Kingdom 13:30 to 13:35
Endovascular treatment of uncomplicated Type B dissection and IRAD Registry Peter Taylor, London, United Kingdom 13:35 to 13:40
Panel discussion 13:40 to 13:50
TEVAR for acute complicated Type B dissection - results of Valiant Captivia US pivotal trial Rodney White, Torrance, United States 13:50 to 13:55
Panel discussion 14:00 to 14:10
Comparing best medical treatment alone with endograft and best medical treatment in acute uncomplicated Type B aortic dissection Jan Brunkwall, Koln, Germany 14:10 to 14:15
Panel discussion 14:20 to 14:30
Technique to occlude the distal false lumen in ruptured Type B dissection Sebastian Debus, Hamburg, Germany 14:30 to 14:35
Treating Type B aortic dissections with a dissection-specific system - updated STABLE trial results Joseph Lombardi, Camden, United States 14:35 to 14:40
Panel discussion 14:40 to 14:45
European experience on custom-made thoracic endografts Vincent Riambau, Barcelona, Spain 14:45 to 14:50
Surgeon-modified fenestrated thoraco-abdominal endografts Mark Fillinger, Lebanon, United States 14:50 to 14:55
Panel discussion 14:55 to 15:05
Why Registry findings are different Thomas Maldonado, New York, United States 15:10 to 15:15
Endovascular management of left subclavian artery during TEVAR - the Valiant left subclavian branched device Eric Roselli, Cleveland, United States 15:15 to 15:20
Panel discussion 15:20 to 15:30
Multilayer stent results at 1 year - moratorium until then Thomas Larzon, Orebro, Sweden 16:30 to 16:35
Update on multilayer flow modulating stent Charles McCollum, Manchester, United Kingdom 16:35 to 16:40
Panel discussion 16:40 to 16:45
RESCUE trial for blunt thoracic aortic injury - results of US pivotal trial with Valiant stent graft Ali Azizzadeh, Houston, United States 16:50 to 16:55
Panel discussion 16:55 to 17:00
Juxta-Renal & Mesenteric Challenges: Parallel, fenestrated and branched graft approaches Chairman Matt Thompson, London, United Kingdom 16:59 to 18:30
The history of snorkel, chimney, periscope and sandwich grafting compared with fenestrated and branched endografting Frank Criado, Baltimore, United States 17:00 to 17:05
Sandwich grafts are superior to custom made devices to treat thoraco-abdominal aortic aneurysms Ralf Kolvenbach, Duesseldorf, Germany 17:10 to 17:15
Hybrid vascular grafts used for aortic de-branching Mario Lachat, Zurich, Switzerland 17:15 to 17:20
Chimney results are good for short aneurysm necks Thomas Larzon, Orebro, Sweden 17:20 to 17:25
Mid-term results of Chimney technique - without Type 1 endoleak Giovanni Torsello, Muenster, Germany 17:25 to 17:30
Panel discussion 17:30 to 17:45
Surgeon-modified fenestrated juxta-renal endografts Mark Fillinger, Lebanon, United States 17:45 to 17:50
Open chimney experience for juxta-renal aneurysm Eric Ducasse, Bordeaux, France 17:50 to 17:55
In situ customisation with off-the-shelf fenestration - Ventana clinical results Andrew Holden, Auckland, New Zealand 17:55 to 18:00
Off-the-shelf fenestrated stent-graft - 6-month results for Zenith p-Branch James F McKinsey, New York, United States 18:00 to 18:05
Comparison of covered and bare metal stents for treatment of critical mesenteric ischemia Gustavo Oderich, Rochester, United States 18:05 to 18:10
Landscape of Error in Aortic Procedures (LEAP) study early stages Colin Bicknell, London, United Kingdom 18:10 to 18:15
Panel discussion 18:15 to 18:30
Tuesday 09 April

Carotid Challenges Chairman Roger Greenhalgh, London, United Kingdom 07:59 to 10:30
Diffusion weighted magnetic resonance imaging in carotid artery investigations Sumaira Macdonald, Newcastle, United Kingdom 08:00 to 08:05
How and why we should measure carotid plaque volume rather than the severity of stenosis Charles McCollum, Manchester, United Kingdom 08:05 to 08:10
Intra-operative functional imaging for assessment of carotid revascularisation Dittmar Boeckler, Heidelberg, Germany 08:10 to 08:15
Panel discussion 08:15 to 08:25
Testing for asymptomatic carotid disease in patients with symptomatic disease elsewhere Ankur Thapar, London, United Kingdom 08:25 to 08:30
Panel discussion 08:35 to 08:45
Practical issues arising from hyper acute carotid intervention Ross Naylor, Leicester, United Kingdom 08:45 to 08:50
Flow diversion for the anterior cerebral circulation Andrew Platts, London, United Kingdom 08:50 to 08:55
Panel discussion 08:55 to 09:05
Embolic material captured by filters during protected carotid artery stenting reflects plaque echogenisity implications for carotid stenting Christos Liapis, Athens, Greece 09:05 to 09:10
Thrombectomy or thrombolysis for acute stroke Andrew Platts, London, United Kingdom 09:10 to 09:15
Panel discussion 09:15 to 09:25
Debate - For the motion: The SVS carotid guidelines are based upon evidence not turf Peter Gloviczki, Rochester, United States 09:25 to 09:30
Debate - Against the motion: The SVS carotid guidelines are based upon evidence not turf William Gray, New York, United States 09:30 to 09:35
Discussion and Vote 09:35 to 09:45
Panel discussion 09:55 to 10:00
Great Debate - For the motion: Robotics and simulators influence beneficially operative carotid procedures Barry Katzen, Miami, United States 10:00 to 10:05
Great Debate - Against the motion: Robotics and simulators influence beneficially operative carotid prodecures George Hamilton, London, United Kingdom 10:10 to 10:15
Great Debate - Against the motion: Robotics and simulators influence beneficially operative carotid prodecures Peter Gloviczki, Rochester, United States 10:15 to 10:20
Discussion and Vote 10:20 to 10:30
Venous Challenges Chairman Ian Franklin, London, United Kingdom 10:29 to 12:30
Advanced imaging for evaluation and follow-up after large vein reconstruction Peter Gloviczki, Rochester, United States 10:30 to 10:35
Imaging for iliac deep vein thrombosis - which modality to use? Gerard O'Sullivan, Galway, Ireland 10:35 to 10:40
Duplex sourcing of reflux in ulcerated limbs Alfred Obermayer, Vienna, Austria 10:40 to 10:45
Panel discussion 10:45 to 10:55
When and how should we treat truncal vein incompetence in patients with venous ulcers? Manj Gohel, Cambridge, United Kingdom 10:55 to 11:00
Pelvic vein incompetence - the facts! Mark Whiteley, Guildford, United Kingdom 11:00 to 11:05
Panel discussion 11:10 to 11:20
Five-year data from the European study of radiofrequency segmental thermal ablation - establishing the gold standard Thomas Proebstle, Mannheim, Germany 11:20 to 11:25
How often do multiple veins need to be ablated in one leg? Lowell Kabnick, Morristown, United States 11:25 to 11:30
Mechanochemical ablation for varicose veins comes of age Steve Elias, Englewood, United States 11:30 to 11:35
Does it matter how the varicose vein is treated by endovenous approach? What about steam? Renate van den Bos, Rotterdam, Netherlands 11:35 to 11:40
Panel discussion 11:40 to 11:45
Randomised controlled trials comparing endovenous thermal and chemical ablation Bo Eklof, Helsingborg, Sweden 11:50 to 11:55
Pharmacological impact on venous disease Albert-Adrien Ramelet, Lausanne, Switzerland 11:55 to 12:00
Panel discussion 12:00 to 12:10
The benefit of cell therapy on venous ulcers Herbert Slade, Fort Worth, United States 12:10 to 12:15
Glue for superficial venous ablation Gerry Stansby, Newcastle-upon-Tyne, United Kingdom 12:15 to 12:20
Cost effectiveness of varicose veins treatment Alun Davies, London, United Kingdom 12:20 to 12:25
Panel discussion 12:25 to 12:30
Venous Challenges: Deep vein thrombosis and pulmonary embolism challenges Chairman Alun Davies, London, United Kingdom 13:29 to 14:45
Epidemiology of chronic venous disease Peter Gloviczki, Rochester, United States 13:30 to 13:35
Panel discussion 13:40 to 13:45
Management of pulmonary embolism - use of EkoSonic system Nils Kucher, Bern, Switzerland 13:45 to 13:50
Thrombus penetration by the EkoSonic system Iris Baumgartner, Bern, Switzerland 13:50 to 13:55
Panel discussion 13:55 to 14:00
Aspirex for deep vein thrombosis Lubomir Spak, Kosice, Slovakia 14:00 to 14:05
How to achieve better results following deep vein thrombosis Cliff Shearman, Southampton, United Kingdom 14:05 to 14:10
What are the indications for surgical venous thrombectomy? Anthony Comerota, Toledo, United States 14:10 to 14:15
Panel discussion 14:15 to 14:20
Genetics and primary venous disease Muzaffar Ali Anwar, London, United Kingdom 14:25 to 14:30
Need for more deep venous valve replacement Hayley Moore, London, United Kingdom 14:30 to 14:35
Panel discussion 14:35 to 14:45
Venous Challenges: Deep vein thrombosis and pulmonary embolism challenges Chairman Mark Whiteley, Guildford, United Kingdom 14:44 to 16:15
Tips and tricks in deep vein reconstruction Peter Gloviczki, Rochester, United States 14:45 to 14:50
Venous ablation should be performed in patients with a history of ipsi-lateral deep vein thrombosis Lowell Kabnick, Morristown, United States 14:50 to 14:55
Panel discussion 14:55 to 15:05
The problem with retrievable inferior vena cava filters: non-retrieval Anthony Comerota, Toledo, United States 15:05 to 15:10
Inferior vena caval filters - evaluating risks and benefits Nicholas Chalmers, Manchester, United Kingdom 15:10 to 15:15
Panel discussion 15:15 to 15:25
REITE Registry on venous thromboembolic disease and post-thrombotic syndrome Marc Cairols, Barcelona, Spain 15:25 to 15:30
Clinical experience with stenting in ilio-femoral obstruction Gerard O'Sullivan, Galway, Ireland 15:30 to 15:35
Panel discussion 15:35 to 15:45
Ilio-caval thrombotic lesions treated by covered stents Jeffrey Wang, Rockville, United States 15:45 to 15:50
Which stent for deep vein occlusive disease? Cees Wittens, Maastricht, Netherlands 15:50 to 15:55
Panel discussion 15:55 to 16:05
ABBOTT SATELLITE Saturday 06 April

ABBOTT SATELLITE: Evolution and revolution in the superficial femoral artery Chairman Mauro Gargiulo, Bologna, Italy 09:59 to 10:30
Femoral anatomy: Characteristics and challenges Frank Vermassen, Ghent, Belgium 10:00 to 10:10
Evolution in superficial femoral artery technology Richard Rapoza, Santa Cruz, United States 10:10 to 10:20
Monday 08 April

Discussion 10:20 to 10:30
CORDIS SATELLITE Saturday 06 April

CORDIS SATELLITE: Iliac/superficial femoral artery interventions today Chairman Roger Greenhalgh, London, United Kingdom 12:29 to 13:30
Nitinol self-expandable stent in the treatment of obstructive superficial femoral artery disease: 2-year results from the STROLL trial William Gray, New York, United States 12:30 to 12:45
Contemporary results on superficial femoral artery fracture rates: Lessons learned on the factors impacting fracture rates and the severity of fracture Dierk Scheinert, Leipzig, Germany 12:45 to 13:00
Chronic total occlusion crossing techniques. Peter Schneider, Honolulu, United States 13:00 to 13:15
Panel Discussion 13:15 to 13:30
ENDOLOGIX SATELLITE Sunday 07 April

ENDOLOGIX SATELLITE: Innovation in aortic aneurysms: From concept to clinical practice Chairman Matt Thompson, London, United Kingdom 15:29 to 16:30
Off-the-shelf custom fenestration - Ventana Jean-Pierre Becquemin, Creteil, France 15:40 to 15:50
Sealing the entire aneurysm - EVAS Andrew Holden, Auckland, New Zealand 15:50 to 16:00
The initial European case experience - Nellix EVAS Paul Hayes, Cambridge, United Kingdom 16:00 to 16:15
The initial European case experience - Nellix EVAS Dittmar Boeckler, Heidelberg, Germany 16:00 to 16:15
Panel discussion 16:15 to 16:30
GORE SATELLITE Saturday 06 April

GORE SATELLITE: New developments in the treatment of complex lower extremity lesions Chairman Eric Verhoeven, Nuremberg, Germany 15:29 to 16:00
What can we expect from ongoing superficial femoral artery endoluminal bypass trials? Current status review! Thomas Zeller, Bad Krozingen, Germany 15:30 to 15:40
Covalent endpoint heparin bonded grafts vs Vein in critical limb ischaemia patients Jan Heyligers, Tiburg, Netherlands 15:50 to 16:00
Sunday 07 April

GORE SATELLITE: Latest clinical outcomes in aortic Endovascular treatment Chairman Peter Taylor, London, United Kingdom 09:59 to 10:30
10 year follow up - low reintervention rate with the Gore Excluder Device (The Italian Registry) Giovanni Pratesi, Florence, Italy 10:00 to 10:10
Have challenges in EVAR treatment changed over the years? Lessons learned from the real life GREAT GORE? C3 REGISTRY Paul Bachoo, Aberdeen, United Kingdom 10:10 to 10:20
Update on a multi-center thoracic Registry Dittmar Boeckler, Heidelberg, Germany 10:20 to 10:30
MAQUET SATELLITE Monday 08 April

MAQUET SATELLITE: New innovative solutions for open & endo surgery Chairman Eric Verhoeven, Nuremberg, Germany 15:29 to 16:30
FLIXENE IFG with assisted delivery, the next innovation in surgery Afshin Assadian, Vienna, Austria 15:50 to 16:10
Use of V12 & LD V12 large diameter covered stents in the treatment of aortoiliac occlusive disease Peter Goverde, Antwerp, Belgium 16:10 to 16:30
MEDTRONIC SATELLITE Sunday 07 April

MEDTRONIC SATELLITE Chairman Ross Milner, Chicago, United States 12:29 to 13:30
ENGAGE vs EUROSTAR: Have modern devices improved outcomes? Marc van Sambeek, Eindhoven, Netherlands 12:30 to 12:40
The hostile neck: What are the anatomic limits? Hence Verhagen, Rotterdam, Netherlands 12:40 to 12:50
Is there still a gender gap with EVAR? Thomas Forbes, London, Canada 12:50 to 13:00
Panel Discussion 13:15 to 13:30
VASCUTEK SATELLITE Monday 08 April

VASCUTEK SATELLITE: Innovations and Updates from Vascutek Chairman Alun Davies, London, United Kingdom 12:29 to 13:30
Anaconda - the Latin American experience Pierre Galvani Silveira, Florianopolis, Brazil 12:30 to 12:45
An update on fenestrated Anaconda Johannes Kalder, Aachen, Germany 12:45 to 13:00
Frozen Elephant Trunk procedure with Thoraflex Hybrid Maximilian Pichlmaier, Munich, Germany 13:00 to 13:15
Discussion 13:15 to 13:30